Lidings is pleased to invite you and your colleagues to a seminar on launching new drugs in the Russian market.

Regulatory incentives and objective economic realities are driving pharmaceutical companies to seek opportunities for launching new drugs. Such projects are now being conceived and implemented not only by innovative companies but also by players who have traditionally specialized in generics and biosimilars.

During our seminar, we will share our experience and propose effective, cost-efficient legal solutions to help businesses safely and promptly execute new launches at any stage.

Effective September 1, 2025, amendments to Article 135 of the Russian Labor Code will come into force: employers will no longer be able to reduce an employee’s bonus by more than 20% of their monthly salary as a result of a disciplinary action.

We have prepared an overview that explores this topic in greater detail: it covers the concept of bonuses, their types, and how they can be formalized in company policies. We hope this material will be useful in your work and help you assess whether updates to internal documents are needed in advance.

• pdf, 10.85 Mb

On August 11, 2025, amendments to the Labor Code of the Russian Federation (hereinafter referred to as the "LC of the RF") entered into force. These amendments concern the provision of guarantees to part-time employees upon termination of an employment contract with them at their primary place of work due to the liquidation of the organization or redundancy or staff cuts at the organization.

On 7 July 2025, Federal Law No. 214-FL «On Amendments to Part Four of the Civil Code of the Russian Federation» was published. This law introduces the following significant changes to the provisions on the recovery of compensation for infringement of exclusive rights to intellectual property and means of individualisation equivalent thereto.

On 14 July 2025, the Council of the State Duma began reviewing Draft Law No. 951518-8 “On Amendments to Article 12 of the Federal Law ‘On Personal Data’” (hereinafter referred to as the “Draft Law”).

On 7 July 2025, the President of the Russian Federation has signed the Federal Law No. 186-FZ of 07.07.2025 “On Amendments to Article 21 of the Federal Law “On Limited Liability Companies" (hereinafter the “Law”), which provides for amendments to the Federal Law No. 14-FZ of 08.02.1998 “On Limited Liability Companies” (hereinafter the “LLC Law”) taking effect on 1 September 2025 regarding the possibility of excluding the pre-emptive right to purchase a share or a part thereof.

On 7 July 2025, the President of the Russian Federation has signed the Federal Law No. 186-FZ of 07.07.2025 “On Amendments to Article 21 of the Federal Law “On Limited Liability Companies" (hereinafter the “Law”), which provides for amendments to the Federal Law No. 14-FZ of 08.02.1998 “On Limited Liability Companies” (hereinafter the “LLC Law”) taking effect on 1 September 2025 regarding the possibility of excluding the pre-emptive right to purchase a share or a part thereof.

On July 11, 2025, a joint letter from the FAS and the Ministry of Health № ТН/61566/25, № 25-7/И/2-13136 dated July 2, 2025 (hereinafter referred to as the "Joint Letter") was published, clarifying the procedure for determining the initial (maximum) contract price (IMCP) in the procurement of pharmaceuticals.

As part of the Lidings Global project and following its series of events focused on the Middle East, Lidings will run a seminar Future of Enforcement of Foreign Award: Russia, CIS, and the Middle East in collaboration with ALC Lawyers ALC Lawyers and Counsels, a leading Omani law firm.

The event will take place on July 22, 2025, at the Oman Commercial Arbitration Centre (OCAC) in Muscat.